When, despite taking chemical medications, my symptoms persist
The FDA declared the tirzepatide shortage resolved on October 2, 2024, and issued a formal declaratory order affirming that resolution
In the U.S., the core molecule patent runs to roughly 2032
If GPX4 inadequately reduces hydroperoxy-PEs, their accumulation will serve as a lethal signal to trigger ferroptosis
It stimulates ACTH and cortisol release (likely through hypothalamic CRH activation), increases prolactin secretion, and potently stimulates appetite through ghrelin-mimetic activity at the GHS-R1a receptor in the arcuate nucleus
This is regardless of whether NVDA retains its top-dog status or is threatened by custom silicon like Sam Altman wishes to create - custom chip numbers are still small, but if they were to ramp up ...just look at what AMD MRVL & AVGO and related stocks did on a few months of upward revisions of few 100K units